Inventor

Sergei Zolotukhin

Inventor
Gainesville, FL, US

Overview

27→
Patents
1997–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes39%
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
PatentTitleYear
11,103,556Satiation peptide administration202111,091,777Synthetic combinatorial AAV capsid library for targeted gene therapy202110,934,327Capsid-modified, RAAV3 vector compositions and uses in gene therapy of human liver cancer202110,815,279Capsid-modified rAAV vector compositions and methods therefor202010,793,606Modified AAV capsid proteins and uses thereof202010,723,768Capsid modified rAAV vectors and methods of use202010,011,640Capsid-modified rAAV vector compositions and methods therefor20189,920,097'Capsid-modified rAAV vector compositions having improved transduction efficiencies, and methods of use'20189,775,918'Capsid-modified rAAV vectors and methods of use'20179,492,505'Satiation peptide administration'20169,157,098'Transduction efficiency, capsid-modified rAAV vectors and methods of use'20158,802,440'Therapeutic methods based on tyrosine-substituted, capsid-modified rAAV vectors'20148,679,837'Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors'20148,445,267'Tyrosine-modified recombinant rAAV vector compositions and methods for use'20137,220,577'Modified AAV'20077,094,604'Production of pseudotyped recombinant AAV virions'20066,967,018'Adiponectin gene therapy'20056,783,972'Methods for large-scale production of recombinant AAV vectors'20046,660,514'Method of preparing recombinant adeno-associated virus compositions'20036,146,874'Method of preparing recombinant adeno-associated virus compositions'20006,020,192'Humanized green fluorescent protein genes and methods'20005,968,750'Humanized green fluorescent protein genes and methods'19995,874,304'Humanized green fluorescent protein genes and methods'19995,741,683'In vitro packaging of adeno-associated virus DNA'19985,688,675'In vitro packaging of adeno-associated virus DNA'19975,688,676'In vitro packaging of adeno-associated virus DNA'19975,677,158'In vitro packaging of adeno-associated virus DNA'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–1998Patents assigned to UNIV NEW YORK STATE RES FOUND (4)· patent assignee history
1997–2021Based in Gainesville, FL, US· patent location history
1999–2021Patents assigned to UNIV FLORIDA (22)· patent assignee history
2013–2016Patents assigned to ZOLOTUKHIN SERGEI (3)· patent assignee history
2013Patents assigned to AGBANDJE-MCKENNA MAVIS (1)· patent assignee history
2016Patents assigned to ACOSTA ANDRES (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV FLORIDA221999–2021
UNIV NEW YORK STATE RES FOUND41997–1998
ZOLOTUKHIN SERGEIself32013–2016
ACOSTA ANDRES12016
AGBANDJE-MCKENNA MAVIS12013
Locations
LocationPatentsSpan
Gainesville, Florida, US271997–2021